Toxicity profile of tandem high-dose chemotherapy with epirubicin, cyclophosphamide and thiotepa (ECT) and stem-cell support in high-risk breast cancer

被引：0
|
作者：
Eimermacher, H
Frick, M
Kalitschke, W
Lindemann, HW
Nitz, U
Adomeit, A
Souchon, R
Scholten, T
机构：
[1] Kath Krankenhaus Hagen, Dept Hematol Oncol, Hagen, Germany
[2] Univ Witten Herdecke, Witten, Germany
[3] Univ Dusseldorf, D-4000 Dusseldorf, Germany
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
SP20
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [1] High-dose chemotherapy with stem cell support in breast cancer: Does cyclophosphamide alter high-dose thiotepa pharmacokinetics?
    Dobrovolskaja, A
    Nitz, U
    Frick, M
    Bender, HG
    Burk, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S37 - S37
  • [2] Pharmacokinetics of thiotepa and mitoxantrone in high-dose chemotherapy with autologous stem cell support of patients with high-risk breast cancer
    Wolkewitz, B
    Hilger, RA
    Skorzec, M
    Markus-Matulla, A
    Mayer, S
    Steiniger, H
    Schneemann, H
    Seeber, S
    Scheulen, ME
    BONE MARROW TRANSPLANTATION, 1998, 22 : S60 - S64
  • [3] High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer
    Rodenhuis, S
    Bontenbal, M
    Beex, LVAM
    Wagstaff, J
    Richel, DJ
    Nooij, MA
    Voest, EE
    Hupperets, P
    van Tinteren, H
    Peterse, HL
    TenVergert, EM
    de Vries, EGE
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01): : 7 - 16
  • [4] High-dose chemotherapy with hematopoietic stem-cell support in breast cancer
    Viens, P
    Maraninchi, D
    BULLETIN DU CANCER, 2001, 88 (09) : 835 - 841
  • [5] High-dose chemotherapy and stem-cell support in breast cancer - Reply
    Rodenhuis, S
    Dalesio, O
    Rutgers, E
    LANCET, 1998, 352 (9135): : 1220 - 1220
  • [6] HIGH-DOSE CARBOPLATIN, THIOTEPA AND CYCLOPHOSPHAMIDE (CTC) WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN THE ADJUVANT THERAPY OF HIGH-RISK BREAST-CANCER - A PRACTICAL APPROACH
    VANDERWALL, E
    NOOIJEN, WJ
    BAARS, JW
    HOLTKAMP, MJ
    SCHORNAGEL, JH
    RICHEL, DJ
    RUTGERS, EJT
    SLAPERCORTENBACH, ICM
    VANDERSCHOOT, CE
    RODENHUIS, S
    BRITISH JOURNAL OF CANCER, 1995, 71 (04) : 857 - 862
  • [7] Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer
    Tallman, MS
    Gray, R
    Robert, NJ
    LeMaistre, CF
    Osborne, CK
    Vaughan, WP
    Gradishar, WJ
    Pisansky, TM
    Fetting, J
    Paietta, E
    Lazarus, HM
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01): : 17 - 26
  • [8] Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow stem-cell transplantation and comprehensive supportive care
    Holland, HK
    Dix, SP
    Geller, RB
    Devine, SM
    Heffner, LT
    Connaghan, DG
    Hillyer, CD
    Hughes, LL
    Miller, RL
    Moore, MR
    Winton, EF
    Wingard, JR
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1156 - 1164
  • [9] Results of tandem high-dose chemotherapy and autologous stem cell transplantation using thiotepa in children with high-risk medulloblastoma
    Daylidite, V.
    Daylidite, Vidmante V.
    Subbotina, Natalia N.
    Dolgopolov, Igor S.
    Babelyan, Stepan S.
    Levashow, Andrey S.
    Mentkevich, Georgy L.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S513 - S513
  • [10] Tandem High-Dose Chemotherapy with Autologous Stem Cell Rescue using Thiotepa/Cyclophosphamide and Busulfan/Melphalan Regimens in Two Cases of High-Risk Neuroblastoma
    Mizushima, Yoshitaka
    Mitani, Yuichi
    Oshima, Koichi
    Mori, Makiko
    Fukuoka, Kohei
    Arakawa, Yuki
    Kawashima, Hiroshi
    Nakazawa, Atsuko
    Koh, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2021, 68
12345